Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Urologic oncology

Showing results (1-10 of 4,822) with videos related to

Pageof 483
Sort By:
Urologic Oncology|September 20, 2022
Recurrence pattern in localized RCC: results from a European multicenter database (RECUR)Giuseppe Fallara, Alessandro Larcher, Saeed Dabestani, et al.
Urologic Oncology|October 13, 2022
Heterogeneity in the pharmacological management of radiation-induced hemorrhagic cystitisBrendan K Wallace, Anton M Gillespie, George W Moran, et al.
Urologic Oncology|December 10, 2014
Commentary on "Optimal schedule of bacillus Calmette-Guérin for non-muscle-invasive bladder cancer: A meta-analysis of comparative studies." Zhu S, Tang Y, Li K, Shang Z, Jiang N, Nian X, Sun L, Niu Y, Department of Urology Tianjin Institute of Urology, 2nd Hospital of Tianjin Medical University, People's Republic of China.: BMC Cancer 2013; 13:332. doi:10.1186/1471-2407-13-332William A See
Urologic Oncology|December 22, 2014
World Urologic Oncology Federation Bladder Cancer Prevention Program: a global initiativeLaurence Klotz, Maurizio A Brausi
Urologic Oncology|December 3, 2014
Commentary on "factors associated with satisfaction with prostate cancer care: results from Cancer of the Prostate Strategic Urologic Research Endeavor (CaPSURE)." Resnick MJ, Guzzo TJ, Cowan JE, Knight SJ, Carroll PR, Penson DF, VA Tennessee Valley Geriatric Research, Education and Clinical Care, Nashville, TN.: BJU Int 2013;111(2):213-20. [Epub 2012 Aug 29]. doi: 10.1111/j.1464-410X.2012.11423.xBrent K Hollenbeck
Urologic Oncology|December 3, 2014
CDK1 and CDK2 activity is a strong predictor of renal cell carcinoma recurrenceFumiya Hongo, Natsuki Takaha, Masakatsu Oishi, et al.
Urologic Oncology|December 3, 2014
Identification of cell-free microRNAs in the urine of patients with prostate cancerNina Korzeniewski, Georgi Tosev, Sascha Pahernik, et al.
Urologic Oncology|December 3, 2014
Feasibility of obtaining biomarker profiles from endoscopic biopsy specimens in upper tract urothelial carcinoma: preliminary resultsBishoy A Gayed, Aditya Bagrodia, Mansi Gaitonde, et al.
Urologic Oncology|December 3, 2014
Radical prostatectomy in high-risk and locally advanced prostate cancer: Mayo Clinic perspectiveSuzanne B Stewart, Stephen A Boorjian
Urologic Oncology|October 24, 2015
Randomized controlled trials in testicular cancer: A demographic and quality assessmentMadhur Nayan, Viranda H Jayalath, Michael A S Jewett, et al.
Pageof 483

Showing results (1-10 of 4,822) with videos related to

Sort By:
Pageof 483
Urologic Oncology|September 20, 2022
Recurrence pattern in localized RCC: results from a European multicenter database (RECUR)Giuseppe Fallara, Alessandro Larcher, Saeed Dabestani, et al.
Urologic Oncology|October 13, 2022
Heterogeneity in the pharmacological management of radiation-induced hemorrhagic cystitisBrendan K Wallace, Anton M Gillespie, George W Moran, et al.
Urologic Oncology|December 10, 2014
Commentary on "Optimal schedule of bacillus Calmette-Guérin for non-muscle-invasive bladder cancer: A meta-analysis of comparative studies." Zhu S, Tang Y, Li K, Shang Z, Jiang N, Nian X, Sun L, Niu Y, Department of Urology Tianjin Institute of Urology, 2nd Hospital of Tianjin Medical University, People's Republic of China.: BMC Cancer 2013; 13:332. doi:10.1186/1471-2407-13-332William A See
Urologic Oncology|December 22, 2014
World Urologic Oncology Federation Bladder Cancer Prevention Program: a global initiativeLaurence Klotz, Maurizio A Brausi
Urologic Oncology|December 3, 2014
Commentary on "factors associated with satisfaction with prostate cancer care: results from Cancer of the Prostate Strategic Urologic Research Endeavor (CaPSURE)." Resnick MJ, Guzzo TJ, Cowan JE, Knight SJ, Carroll PR, Penson DF, VA Tennessee Valley Geriatric Research, Education and Clinical Care, Nashville, TN.: BJU Int 2013;111(2):213-20. [Epub 2012 Aug 29]. doi: 10.1111/j.1464-410X.2012.11423.xBrent K Hollenbeck
Urologic Oncology|December 3, 2014
CDK1 and CDK2 activity is a strong predictor of renal cell carcinoma recurrenceFumiya Hongo, Natsuki Takaha, Masakatsu Oishi, et al.
Urologic Oncology|December 3, 2014
Identification of cell-free microRNAs in the urine of patients with prostate cancerNina Korzeniewski, Georgi Tosev, Sascha Pahernik, et al.
Urologic Oncology|December 3, 2014
Feasibility of obtaining biomarker profiles from endoscopic biopsy specimens in upper tract urothelial carcinoma: preliminary resultsBishoy A Gayed, Aditya Bagrodia, Mansi Gaitonde, et al.
Urologic Oncology|December 3, 2014
Radical prostatectomy in high-risk and locally advanced prostate cancer: Mayo Clinic perspectiveSuzanne B Stewart, Stephen A Boorjian
Urologic Oncology|October 24, 2015
Randomized controlled trials in testicular cancer: A demographic and quality assessmentMadhur Nayan, Viranda H Jayalath, Michael A S Jewett, et al.
Pageof 483